Concepedia

Nadja Schöler

NS

Statistics

Publications

5

Citations

513

H-Index

5

Active since

2000

Affiliations

Freie Universität Berlin(Current)

Max Planck Institute for Infection Biology

Nadja Schöler is an author at Freie Universität Berlin specializing in nanomedicine, macrophage biology, and immunology.

Publications per year

2000–2004

5

Publications

5

Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages

Nadja Schöler, Carsten Olbrich, Kerstin Tabatt et al. · International Journal of Pharmaceutics · 2001 · 147 citations

Life Sciences, Cell Biology, Immunology +14

Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages

Nadja Schöler, Helmut Hahn, Rainer Müller et al. · International Journal of Pharmaceutics · 2002 · 145 citations

Life Sciences, Cell Biology, Immunology +16

Atovaquone Nanosuspensions Show Excellent Therapeutic Effect in a New Murine Model of Reactivated Toxoplasmosis

Nadja Schöler, Karsten Krause, Oliver Kayser et al. · Antimicrobial Agents and Chemotherapy · 2001 · 141 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +15

Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages—impact of phagocytosis on viability and cytokine production

Carsten Olbrich, Nadja Schöler, Kerstin Tabatt et al. · Journal of Pharmacy and Pharmacology · 2004 · 45 citations · Full text

Pharmacy, Immunology, Toxicology +17

Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages

Nadja Schöler, E Zimmermann, Ulrike Katzfey et al. · International Journal of Pharmaceutics · 2000 · 35 citations

Life Sciences, Immunology, Toxicology +16

1–5 of 5